Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
London, United Kingdom
SEC filing record 1 source field available
Fiscal year end
31 December
Orchard Therapeutics plc has filed 339 SEC EDGAR filings since 06 Aug 2018

SEC filing history

Showing 251-275 of 339 matching filings.

Per page
25
Current page
11
3

PRIMARY DOCUMENT

Filing date
02 Jan 2020
Reporting date
02 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
02 Jan 2020
Reporting date
01 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
02 Jan 2020
Reporting date
01 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
02 Jan 2020
Reporting date
01 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
02 Jan 2020
Reporting date
01 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
02 Jan 2020
Reporting date
01 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
02 Jan 2020
Reporting date
01 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
02 Jan 2020
Reporting date
01 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
02 Jan 2020
Reporting date
01 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
02 Jan 2020
Reporting date
01 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
02 Jan 2020
Reporting date
01 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
02 Jan 2020
Reporting date
01 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38722

6-K

Filing date
02 Dec 2019
Reporting date
02 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38722

6-K

Filing date
18 Nov 2019
Reporting date
18 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38722

6-K

Filing date
13 Nov 2019
Reporting date
13 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38722

6-K

Filing date
06 Nov 2019
Reporting date
06 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
F-3ASR File 333-234439

F-3ASR

Filing date
01 Nov 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38722

6-K

Filing date
22 Oct 2019
Reporting date
22 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38722

6-K

Filing date
30 Sep 2019
Reporting date
30 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38722

6-K

Filing date
13 Sep 2019
Reporting date
13 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38722

FORM 6-K - 4 SEPT 2019

Filing date
04 Sep 2019
Reporting date
04 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38722

6-K 8-30-2019

Filing date
30 Aug 2019
Reporting date
30 Aug 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38722

6-K

Filing date
30 Jul 2019
Reporting date
30 Jul 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .